Hawaii Department Of Health

The Hawaii Department of Health Alcohol and Drug Abuse Division, a state government entity and child division of the State of Hawaii, operates as a federal grant recipient and federal contractor, delivering substance abuse prevention, treatment, recovery services, and tobacco retail compliance inspection to the Department of Health and Human Services on a cost-reimbursement and cost-no-fee basis with no competitive set-asides applied.

ADAD's award portfolio is concentrated almost entirely within HHS. The top funding sources by award count are SAMHSA (37 awards combined across its Center for Substance Abuse Treatment and Center for Substance Abuse Prevention), the Health Resources and Services Administration (9 awards), and the Food and Drug Administration (7 awards carrying $9.6 million in combined potential value). These five customer lines account for 79% of ADAD's 71 total awards. The FDA tobacco inspection work, while smaller in award count, anchors the dollar concentration: a single Indefinite Delivery Contract valued at $3.79 million runs through September 2029, with three delivery orders issued to date (September 2024, May 2025, and May 2026) totaling $2.5 million in combined potential value. The most recent FDA delivery order, issued May 30, 2026, carries a $915 thousand ceiling through May 29, 2027, and requires ADAD to conduct undercover inspections of tobacco retailers across Hawaii, recruiting and training underage purchasers to monitor age-of-sale compliance.

On the grant side, ADAD acts as prime recipient for recurring SAMHSA block grants supporting substance abuse prevention and treatment services statewide. Recent major grants include a $6.59 million Substance Abuse Prevention, Treatment, and Recovery Services Block Grant (CFDA 93.959) running through September 2027, a Hawaii State Opioid Response grant (Hawaii SOR 4) through September 2027 addressing opioid and stimulant use disorder treatment and recovery across rural and underserved populations, and a $5.5 million Overdose Data to Action in States cooperative agreement with the National Center for Injury Prevention and Control running through August 2028 that implements surveillance and prevention strategies for opioid overdose reduction. ADAD also holds a Strategic Prevention Framework Partnerships for Success grant from SAMHSA's Center for Substance Abuse Prevention, running through September 2028, which develops statewide prevention system capacity targeting underage drinking, marijuana, tobacco, and electronic cigarette use in underserved and culturally specific populations including Native Hawaiian and LGBTQ+ communities.

Activity has remained modest and variable — four awards in 2024, two in 2025, and one thus far in 2026 — with four awards (combined potential value $916 thousand) reaching ultimate completion within the next twenty-four months. Four awards out of 71 represent recompete exposure in that window. Service Contract Inventory captures limited ADAD federal service work: SCI records show $369 thousand in invoiced federal service revenue across FY2023 alone, delivered by approximately 1.0 FTE, at a government-paid rate of $52.28 per hour. SCI is a partial view and excludes grant work, goods, micro-purchases, and classified contracts; the vast majority of ADAD's federal footprint resides in grant funding rather than service contracts. ADAD operates exclusively as a prime on its federal awards and does not subcontract; across SCI-reportable prime contracts, subcontractors accounted for an average 18% of contractor hours, with one named subcontractor reported. ADAD's federal work is performed in Kapolei, Hawaii and statewide across Hawaii's rural islands and communities.